Clinical surgery–internationalSentinel lymph node mapping with technetium-99m colloidal rhenium sulfide in patients with gastric carcinoma
Section snippets
Patients
Fifty-nine patients (41 males and 18 females) with histologically confirmed primary gastric adenocarcinoma and without clinically diagnosed lymph node metastasis and distant metastasis were prospectively enrolled in this study. Patients with a diagnosis of clinical T1, T2, or T3N0H0 (liver metastasis) M0 (distant metastasis) status were enrolled in this study. Furthermore, differentiated mucosal tumors of less than 2 cm without an ulcer formation were excluded for endoscopic mucosal resection,
Patient characteristics
The clinicopathologic characteristics of patients enrolled in the study are summarized in Table 1. The depth of cancer invasion was T1 in 28 patients, T2 in 19, and T3 in 12. There were no complications or side effects related to the injection of technetium-99m colloidal rhenium sulfide.
Lymph node status
A total of 2049 nodes were removed; the median number of resected nodes per patient was 35 (range 5 to 81). One hundred twenty-four (6.0%) of these nodes were positive for carcinoma metastasis in permanent
Comments
Although SLN mapping is proving to be a useful technique, there is no standard technique for gastric cancer in Japan and other countries [5], [6], [7], [8] Furthermore, it has been reported that the use of SLN biopsies during gastric cancer surgery cannot be implemented until diagnostic procedures are improved [9]. In this study, SLN mapping with technetium-99m colloidal rhenium sulfide was demonstrated to be effective for detecting SLNs in individuals with early gastric cancer. The SLN
Conclusion
SLN mapping with the use of technetium-99m colloidal rhenium sulfide can be used to detect the sentinel lymph nodes in patients with clinical T1 gastric cancer. However, several issues, such as the sensitivity of intraoperative pathologic examination and the detection of the so-called skip metastasis, remain to be resolved before wide clinical application of this procedure. At present, SLN mapping is suitable for the identification of the lymphatic basin and the performance of selective
References (16)
- et al.
Application of sentinel node biopsy to gastric cancer surgery
Surgery
(2001) - et al.
Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques
J Am Coll Surg
(2003) - et al.
Evaluation of colloid size for sentinel node detection using radioisotopes in early gastric cancer
Cancer Lett
(2003) - et al.
Technical details of intraoperative lymphatic mapping for early stage melanoma
Arch Surg
(1992) - et al.
Lymphatic mapping and sentinel lymphadenectomy for breast cancer
Ann Surg
(1994) - et al.
Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms
Cancer J Sci Am
(1998) - et al.
Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging
Ann Surg Oncol
(2000) - et al.
Radio-guided sentinel node detection for gastric cancer
Br J Surg
(2002)
Cited by (31)
Sentinel lymph node biopsy using carbon nanoparticles for Chinese patients with papillary thyroid microcarcinoma
2012, European Journal of Surgical OncologyCitation Excerpt :SLNB is a minimally invasive operation for staging regional LNs in a malignant tumor. The SLN technique has acquired an important role in cancer surgery22–30; that is, it defines LN status and guides LN dissection. However, some questions remain regarding surgical techniques, indications, labeling, and pathological examination of the removed SLNs.
Sentinel lymph node biopsy to direct treatment in gastric cancer. A systematic review of the literature
2011, European Journal of Surgical OncologyCitation Excerpt :The mean and median percentages for the sensitivity were 85.4% and 88.9% respectively with a wide range from 45.5% to 100%. Low sensitivity percentages of less than 90% were observed in 13/21 studies.10–12,14,17,20–26 In two of the 13 studies better sensitivity percentage of 90–100% was obtained by using the combination method, 9,24 while one showed a similar result with IREE.18
Rhenium Sulfide Nanoparticles as a Biosafe Spectral CT Contrast Agent for Gastrointestinal Tract Imaging and Tumor Theranostics in Vivo
2019, ACS Applied Materials and InterfacesTechnetium Stabilization in Low-Solubility Sulfide Phases: A Review
2018, ACS Earth and Space Chemistry
Supported by Grant No. 13671280 from the Ministry of Education, Science, and Culture of Japan.